Insys Therapeutics (INSY): granted Fast Track designation

• Insys Therapeutics: FDA has granted Fast Track designation to the company's cannabidio oral solution for the treatment of Prader-Willi syndrome; co plans to start the clinical development program in late first quarter of 2018